OBJECTIVE: Oxidative stress is implicated in the pathophysiology of diabetes mellitus and its chronic complications. The aim of this study was to evaluate plasma antioxidant status in patients with uncomplicated type 2 diabetes, in order to understand the interactions between its components and the diabetic milieu. METHODS: Plasma samples were collected from 15 patients with type 2 diabetes receiving oral antidiabetic agents and from 18 healthy control subjects without diabetes. Glycosylated haemoglobin was measured as an indicator of blood glucose control. Total and residual antioxidant activities were measured. Lipid peroxides were measured as indicators of plasma oxidative stress.
Introduction
Oxidative stress is an important factor in the pathogenesis of many chronic diseases, including diabetes. 1 Chronic exposure to elevated levels of glucose, which is the main characteristic of the diabetic milieu, increases the production of reactive oxygen species (ROS) and generates oxidative stress in islet cells. 2 The β-cell contains very low levels of antioxidant enzymes and is, therefore, extremely vulnerable to oxidative stress. 2 ROS impair β-cell glucose-mediated insulin secretion and the regulation of mass regeneration via detrimental effects on O Savu, C Ionescu-Tirgoviste, V Atanasiu et al.
Plasma antioxidants in type 2 diabetes mitochondrial function. 3 There is evidence of a link between ROS damage and the development of microvascular and macrovascular complications in diabetes. 4 Oxidative stress and chronic hyperglycaemia are the main factors in the development of diabetic complications, possibly exerting their effects via hyperglycaemia-induced ROS overproduction by the mitochondrial electron-transport system. 5 Studies using antioxidants have suggested a pivotal role for oxidative stress in glucotoxicity, where insulin gene expression was preserved in the presence of high glucose levels. 2 The relationships between antioxidant status, glycaemic control and the development of chronic diabetic complications are still under debate.
Diabetes mellitus is associated with altered transition-metal metabolism. 3,6 -8 Copper and zinc are essential for balanced oxidant/antioxidant mechanisms. 9 Copper acts as a pro-oxidant and is necessary for the catalytic activity of superoxide dismutase (SOD), which protects against the superoxide radical. 10, 11 An imbalance in the redox mechanism may contribute to the pathogenesis of diabetes mellitus and its complications. 12, 13 The importance of a copper metabolism imbalance has been reported in diabetic complications, 14 especially in the aetiology of peripheral vascular dysfunction and peripheral neuropathies. 15 The aim of the present study was to compare the total plasma antioxidant capacity of patients with uncomplicated type 2 diabetes with that of healthy subjects without diabetes. The metabolism of copper was analysed in relation to plasma caeruloplasmin activity.
Patients and methods

STUDY POPULATION
This case-control study was conducted at the National Institute of Diabetes, Nutrition and Metabolic Diseases 'NC Paulescu', Bucharest, Romania between January 2007 and January 2009. Patients with uncomplicated type 2 diabetes, defined according to American Diabetic Association criteria, 16 were sequentially enrolled in the study. Exclusion criteria were inflammatory or infectious disease, active liver disease, current immunosuppressive therapy and vitamin C or E supplementation. All patients with diabetes were receiving oral antidiabetic agents for glycaemic control, with a target glycosylated haemoglobin (HbA 1c ) of < 7%.
Healthy staff members were recruited as control subjects. Control subjects were required to have normal routine haematological and urinalysis findings and not to be taking any medications.
Age, duration of diabetes and body mass index (BMI; kg/m 2 ) were recorded for all of the study participants, as appropriate.
Written informed consent was obtained from all study participants. The study was approved by the Ethical Committee of the National Institute of Diabetes, Nutrition and Metabolic Diseases 'NC Paulescu' (reference number 175/2007).
REAGENTS AND PLASMA PREPARATION
After overnight fasting, blood (10 ml) was collected from each participant by venepuncture and collected into 2-ml vacutainer tubes containing 34 IU lithium heparin.
Plasma was isolated by centrifugation at 548 g for 15 min at 4°C, and retained on ice until assayed. All reagents were incubated with Chelex ® 100 (Merck, Darmstadt, Germany; final concentration 2%) at room temperature for 4 h, with gentle shaking to bind transitional metals. Reagents were of pure analytical O Savu, C Ionescu-Tirgoviste, V Atanasiu et al.
Plasma antioxidants in type 2 diabetes quality and were purchased from Sigma-Aldrich Chemie (Munich, Germany), if not otherwise indicated. Spectro photo metric assays were performed in triplicate using a Lambda EZ 210 spectrometer (Perkin-Elmer, Foster City, CA, USA).
ANTIOXIDANT ACTIVITY
Total antioxidant activity was determined based on the 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) equivalent antioxidant capacity (TEAC) assay developed by Miller and Rice-Evans, 17 with minor modifications. 18 The TEAC assay measures the relative abilities of antioxidants to scavenge the 2,2′-azino-bis(3ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical cation (ABTS x+ ) in comparison with the antioxidant potency of standard amounts of Trolox, the water soluble vitamin E analogue. The ABTS radical was generated from the interaction between ABTS and potassium persulphate. Plasma samples (10 µl) were mixed with 1 ml of 47 µM ABTS x+ and incubated for 1 min at 30°C. Optical density (absorbance) was read at 734 nm against 5 mM phosphate-buffered saline (pH 7.4). The percentage inhibition of absorbance was calculated. The assay was calibrated against a Trolox standard curve, and the results were expressed as mmol/l Trolox.
Plasma residual antioxidant activity ('antioxidant gap'; GAP) was calculated by subtracting the antioxidant activity of albumin and uric acid (the principal antioxidants in human plasma) 19 from the total TEAC value, according to the formula: GAP = TEAC -[(albumin × 0.69) + uric acid]; where the TEAC value for plasma albumin is 0.69 and the value for plasma uric acid is 1.0 (albumin, plasma albumin concentration [mmol/l]; uric acid, plasma uric acid concentration [mmol/l]). The results were expressed as mmol/l Trolox.
CAERULOPLASMIN ACTIVITY
Caeruloplasmin activity was determined based on its oxidase function. 20 Freshly isolated plasma (50 µl) was incubated with 200 µl of 7.88 mmol/l o-dianisidine and 750 µl of 0.1 M acetate buffer (pH 5.0) for 15 min at 37°C. Parallel reactions were stopped after 5 and 15 min with 2 ml of 9 M sulphuric acid, and the optical density was read at 540 nm. The optical density at 5 min was subtracted from the optical density at 15 min, and enzymatic activity was expressed as U/l. 20
LIPID PEROXIDE TEST
Plasma (100 µl) was mixed with 50 µl of 2% butylated hydroxytoluene (to prevent lipid oxidation during the assay), 1.5 ml thiobarbituric acid (TBA; final concentration 0.67%) and 0.5 ml trichloracetic acid (final concentration 20%), and incubated at 100°C for 1 h. The reaction was stopped by cooling the samples under tap water. The pink malondialdehyde (MDA)-TBA adduct was extracted in n-butanol and the absorbance of the organic layer was read at 532 nm after centrifugation at 8000 g for 15 min at 4°C. The concentration of lipid peroxidation products was calculated as MDA equivalents 21 and expressed as nmol/ml. A 1,1,3,3-tetramethoxypropane standard curve was prepared for each run.
BIOCHEMICAL ANALYSES
Plasma albumin, uric acid, total protein and copper were quantified using commercially available kits (albumin, uric acid and total protein: DiaSys Diagnostic Systems, Germany; copper: Spinreact, Gerona, Spain). Plasma HbA 1c was quantified using standardized immunoturbidimetry on a Cobas Integra ® 400 Plus analyser (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions.
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STATISTICAL ANALYSES
All data were presented as adjusted predictive values based on a linear regression model, using age and BMI as independent variables. No data imputations were performed. The data were, therefore, corrected for age and BMI as potential confounders. The Student's t-test was used for between-group comparisons. The strength of association between pairs of variables was assessed using Pearson's correlation coefficient. Data analyses were performed using IBM ® SPSS ® statistics, version 20 (IBM Corporation, Armonk, NY, USA). A P-value < 0.05 was considered statistically significant.
Results
The study recruited 15 patients with uncomplicated type 2 diabetes and 18 healthy control subjects. The demographic and clinical characteristics of the participants are shown in Table 1 . Plasma HbA 1c concentrations were significantly higher in patients than in controls (P = 0.001). The patients with diabetes were also significantly older and had a significantly higher BMI than the control subjects (P = 0.0003 and P = 0.0002, respectively).
Data regarding oxidative stress-related parameters are shown in Fig. 1 . Total and residual plasma antioxidant activities (Figs 1A, 1B) and lipid peroxide concentrations (Fig. 1C) were significantly higher in patients with diabetes compared with control subjects (P < 0.003, P < 0.003 and P < 0.001, respectively). Concentrations of plasma albumin were significantly lower, and uric acid significantly higher, in patients than controls (P = 0.017 and P = 0.002, respectively; Fig. 1D ). There was a positive correlation between plasma uric acid concentration and GAP in patients with diabetes (r = 0.94, P < 0.001) There were no other statistically significant correlations. Significantly higher plasma copper concentrations and caeruloplasmin activity were found in patients with type 2 diabetes compared with control subjects (P = 0.0002 and P = 0.0005, respectively; Fig. 2 ).
Discussion
Patients with uncomplicated type 2 diabetes were shown to be subjected to higher oxidative stress (as demonstrated by increased plasma levels of lipid peroxides) than control subjects in the present study. This finding was consistent with a study in which patients with diabetes were shown to O Savu, C Ionescu-Tirgoviste, V Atanasiu et al.
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have higher levels of various ROS markers. 22 Lipid peroxidation is a well established mechanism of ROS-mediated oxidative damage, and the measurement of MDA is a convenient method for its quantification. 23 The synergistic effect of antioxidants in human plasma is known to provide greater protection against free radical aggression than any single antioxidant alone. 24 The current study measured the total antioxidant activity of plasma because of its established ability to withstand oxidative stress. 25 Total and residual plasma antioxidant status were both significantly higher in patients with diabetes compared with control subjects, in the present study. It has been reported that different antioxidants can be generated depending on which ROS are produced. 26 Plasma antioxidant status can, therefore, vary according to which antioxidant is quantified. 27 Similar differences have been observed in plasma vitamin E concentrations in experimental models of diabetes. 27 Significantly increased plasma uric acid concentrations were present in patients with diabetes in the current study, and these correlated positively with residual antioxidant activity. This is in accordance with studies that found the pro-oxidant action of hyperuricaemia to be an independent risk factor for cardiovascular death. 28, 29 The well-documented antioxidant effect of uric acid cannot be excluded, however. 30 Significantly reduced plasma O Savu, C Ionescu-Tirgoviste, V Atanasiu et al.
albumin concentrations were observed in patients with type 2 diabetes compared with control subjects in the present study, and this may be explained by the proinflammatory state that characterizes the diabetic milieu. 31 The antioxidant reserves of the body were, therefore, preserved at the plasma level in this current group of patients with uncomplicated type 2 diabetes and low levels of exposure to chronic hyperglycaemia. The plasma mineral content of patients with type 2 diabetes and the role of trace elements (i.e. copper, zinc and iron) in the pathogenesis of diabetes and diabetic complications remain controversial. 6, 9, 15 Patients with type 2 diabetes in the current study had significantly higher plasma copper concentrations than control subjects; a finding that was in accordance with other studies. 32 The significantly increased caeruloplasmin activity observed in patients in the current study was not unexpected because the majority of plasma copper is found in this protein. 33 It is not possible to determine whether this reflects a pro-or antioxidant effect, since both copper and caeruloplasmin have either antioxidative or pro-oxidative potential depending on conditions, as is the case for all compounds that are redox reactive. 34, 35 It should be noted, however, that the use of specific copper chelators improves cardiac function in patients with diabetes. 36 In conclusion, this study found increased levels of oxidative stress, despite higher antioxidant capacity, in the plasma of patients with uncomplicated type 2 diabetes compared with healthy control subjects. Increased copper metabolism characterized the diabetic milieu, despite an absence of chronic complications. 
